Tom Gibbs
InvestorSenior Investment Director, Debiopharm Innovation Fund S.A. at Debiopharm Innovation Fund
Lausanne, Vaud, Switzerland
Find your path to Tom
34 people in our graph share verified history with Tom — schools, employers, funds. One of them is your warm intro.
About
Tom Gibbs is Senior Investment Director of the Debiopharm Innovation Fund at Debiopharm Group, where he handles the sourcing, evaluation, negotiation, and ongoing support of portfolio investments, alongside board and committee participation. He currently serves as a board member of Nucleai, BC Platforms, and Immunexpress, with prior board roles at companies including Carevive, Acteon, Kaiku Health, Biocartis, GenePOC, Diagnoplex, and TCLand. His earlier career includes work as a Business Development Manager across life science technology supplies and the biopharma industry, covering product development, marketing, and support for hardware, software, and reagent products.
Contact· self-published, not guessed
Experience
- DebiopharmSenior Investment Director, Debiopharm Innovation Fundcurrent2023 — presentLausanne Area, Switzerland
- DebiopharmInvestment Director, Debiopharm Innovation Fund2017 — 2023Lausanne, Vaud, Switzerland
- DebiopharmDirector of BD&L at Debiopharm International, Director at Debiopharm Diagnostics2013 — 2017Lausanne, Vaud, Switzerland
- DebiopharmAssociate Director of Business Development and Licensing2012 — 2013Lausanne, Vaud, Switzerland
- Parker Hannifin EuropeBusiness Development Manager Life Sciences EMEA2011 — 2012Lausanne, Vaud, Switzerland
- Med DiscoveryDirector of Operations2007 — 2011Geneva, Geneva, Switzerland
- Covalys BiosciencesHead of Marketing2004 — 2006Basel, Basel, Switzerland
- Cytion SAProduct Manager2001 — 2003Lausanne, Vaud, Switzerland
- Molecular Devices CorpProduct Manager, Biosensor Systems1999 — 2001Sunnyvale, California
- Molecular Devices CorpApplications and Support Scientist1995 — 1999Sunnyvale, California
- Delta BiotechnologyQuality Assurance Molecular Biologist1989 — 1995Greater Nottingham
Skills & more
+6 more
Product LaunchQuality AssuranceRStrategyTechnology TransferValidationFrom Tom's professional profile.
Colleagues at Debiopharm Innovation Fund
Frequently asked questions
- Who is Tom Gibbs?
- Tom Gibbs is Senior Investment Director of the Debiopharm Innovation Fund at Debiopharm Group, where he handles the sourcing, evaluation, negotiation, and ongoing support of portfolio investments, alongside board and committee participation. He currently serves as a board member of Nucleai, BC Platforms, and Immunexpress, with prior board roles at companies including Carevive, Acteon, Kaiku Health, Biocartis, GenePOC, Diagnoplex, and TCLand. His earlier career includes work as a Business Development Manager across life science technology supplies and the biopharma industry, covering product development, marketing, and support for hardware, software, and reagent products.
- Where does Tom Gibbs work?
- Tom Gibbs is Senior Investment Director, Debiopharm Innovation Fund S.A. at Debiopharm Innovation Fund.
- Where did Tom Gibbs go to school?
- Tom Gibbs studied at University of Warwick (PhD, Microbial Genetics); University of Wales Institute of Science and Technology (BSc, Applied Biology).
Same school
Also attended University of Warwick254
+ 248 more
Shared employers
Also worked at Debiopharm9
+ 3 more
Also worked at Parker Hannifin Europe15
+ 9 more
Also worked at Covalys Biosciences1
Also worked at Molecular Devices Corp9
+ 3 more
































